Obesity is a risk factor for CRC and induces the upregulation of lipid metabolic enzymes, such as fatty acid synthase (FASN) and acetyl-coenzyme carboxylase (ACC). Here, FASN is linked to obesity due to melanocortin 4 receptor deficiency.